Bottom line
FHCRX vs FHLC: the short answer
FHCRX (Health Care Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 152 for FHCRX, so beyond the top names it adds exposure FHCRX doesn't have.
FHLC is cheaper at 0.084% vs 0.55% — a difference of $47 a year per $10,000 invested.
Updated Nov 19, 2026
FHCRX vs FHLC side by side
| FHCRX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.55% | 0.084% |
| Annual cost per $10k | $55 | $8.4 |
| 10-yr cost on $10k (prospectus) | $689 | $108 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +2.6% |
| 5-yr return (annualized) | — | +7.2% |
| 10-yr return (annualized) | — | +8.8% |
| Best quarter | +22.2% | +16.4% |
| Worst quarter | −15.0% | −13.1% |
| Net assets (fund) | $5.8B | $3.3B |
| Number of holdings | 152 | 337 |
| Portfolio turnover | 69% | 3% |
| Returns as of | — | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of FHCRX's top 25 holdings also appear in FHLC's top 25.
| Holding | FHCRX | FHLC |
|---|---|---|
| ELI LILLY and CO | 8.03% | 13.35% |
| Danaher Corp | 6.89% | 1.80% |
| JOHNSON and JOHNSON | 4.91% | 8.93% |
| Thermo Fisher Scientific Inc | 4.33% | 3.09% |
| Unitedhealth Group Inc | 3.49% | 5.44% |
| Gilead Sciences Inc | 2.21% | 2.34% |
| Boston Scientific Corp | 2.17% | 1.00% |
| Abbvie Inc | 2.03% | 6.42% |
| MERCK and CO INC | 1.60% | 4.66% |
| Cvs Health Corp | 1.29% | 1.92% |
| Cencora Inc | 1.14% | 0.83% |
Source: SEC Form N-PORT
FHCRX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between FHCRX and FHLC?
Which is cheaper, FHCRX or FHLC?
Should I own both FHCRX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.